Dr Claire Meaney

Dr Claire Meaney

Junior Council Member

Dr. Claire Meaney is a member of the Research, Development and Innovation team at Limerick Institute of Technology and Principal Investigator within the Shannon Applied Biotechnology Centre. She received her B. Eng in Biomedical Engineering from the University of Limerick and was awarded an Irish Research Council scholarship to conduct her doctoral studies under the supervision of Prof. Tim McGloughlin within the Centre of Applied Biomedical Engineering Research in the University of Limerick’s School of Engineering. Her thesis examined the flow induced stress response of arterial cells with naturally derived vascular graft materials.

After successfully completing her Ph.D at the University of Limerick, Claire was awarded a position on the USA’s National Cancer Institute, Cancer Prevention Fellowship Program. This postdoctoral program was co-funded by the Health Research Board and the National Institutes of Health, USA. As part of Claire’s post-doctoral work, she was funded by the Irish Health Research Board to complete a Masters of Public Health at University College Dublin and her dissertation focused on breast cancer survival characteristics in relation to trastuzumab treatment over a ten year period.

Upon completing her M.P.H., Dr. Meaney and spent three and a half years at the US National Cancer Institute in Bethesda, Maryland, conducting research in biomarker development under the mentorship of Dr. Brid Ryan, and 3D models of tumour microenvironments at the Laboratory of Human Carcinogenesis and Division of Cancer Prevention. While completing her post-doctoral work, Dr. Meaney was competitively selected as a recipient of the 2016/2017 National Cancer Institute, Sallie Rosen Kaplan Leadership Award for Women in Science and served as a Technology Transfer Ambassador for the National Cancer Institute’s collaborative technology transfer programme with Johns Hopkins University and local biotech stakeholders. During her time at the NIH, Dr. Meaney managed multiple research projects, teaching activities, leadership and grant writing training programmes, and worked as part of a team in the development and management of extramural grant mechanisms within the National Institutes of Health Small Business Innovation Research (SBIR) Program.

Upon her return to Ireland, Dr Meaney was awarded a reintegration award to from the Irish Cancer Society and Health Research Board to fund her lung cancer research program in Ireland and began working as an independent principal investigator. The focus of Dr. Meaney’s current research is the computational evaluation of morphologic tumour tissue features as diagnostic and prognostic predictors of lung cancer using digital pathology platforms. Dr. Meaney joined the IACR Junior Council in 2019.

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

IACR Membership

We have a number of membership categories available. Find out which membership suits you.

IACR Conference

Due to COVID restrictions we have yet to confirm the dates for 57th Annual Conference. 

Please check back here later in 2020 to check for updates. 

IACR Public Engagement

Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?

Latest News

Education Grants

The Irish Association for Cancer Research will support a limited number of Educational Grants that
will be made available to postgraduate PhD researchers who have been affected by the Covid-19
pandemic. We acknowledge that many of our members have been significantly impacted by the
recent pandemic that may have affected their ability to continue and/or complete research projects.

FACEBOOK

Irish Association
for Cancer Research  

9A Coolkill, Sandyford
Dublin 18, Ireland
D18 C1W3

info@iacr.ie
+353 (0)295 8859

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.

Registered Charity Number (RCN): 20030117.

©Design by LetterEleven